1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Gene Synthesis Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Prevalence of chronic conditions among the global population
5.1.1.2. Advancements in genomics research and rising demand for personalized medicines
5.1.1.3. Increasing investments by private and public sector in pharmaceutical research
5.1.2. Restraints
5.1.2.1. Strict regulations governing gene synthesis and high cost associated with the process
5.1.3. Opportunities
5.1.3.1. Emerging new technologies in gene synthesis
5.1.3.2. Utilization of gene synthesis in energy and agriculture industries
5.1.4. Challenges
5.1.4.1. Limitations in size and complexity of synthetic genes
5.2. Market Segmentation Analysis
5.2.1. Product: Expanding usage of software that helps design synthetic genes accurately
5.2.2. Method: Rising utilization of chip-based synthesis for large-scale projects
5.2.3. Gene Type: Growing potential for express gene synthesis that provides quick access to shorter genes for time-sensitive projects
5.2.4. End-use: Increasing focus on innovative drug discovery and therapeutic development across biotechnology and pharmaceutical companies
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Gene Synthesis Market, by Product
6.1. Introduction
6.2. Services
6.3.1. Antibody DNA Synthesis
6.3.2. Viral DNA Synthesis
6.3. Software
7. Gene Synthesis Market, by Method
7.1. Introduction
7.2. Chip-Based Synthesis
7.3. PCR-Based Enzyme Synthesis
7.4. Solid-Phase Synthesis
8. Gene Synthesis Market, by Gene Type
8.1. Introduction
8.2. Complex Gene
8.3. Express Gene
8.4. Standard Gene
9. Gene Synthesis Market, by Application
9.1. Introduction
9.2. Disease Diagnosis
9.3. Gene & Cell Therapy Development
9.4. Vaccine Development
10. Gene Synthesis Market, by End-use
10.1. Introduction
10.2. Academic & Government Research Institutes
10.3. Biotechnology & Pharmaceutical Companies
10.4. Contract Research Organizations
11. Americas Gene Synthesis Market
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States
12. Asia-Pacific Gene Synthesis Market
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam
13. Europe, Middle East & Africa Gene Synthesis Market
13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom
14. Competitive Landscape
14.1. FPNV Positioning Matrix
14.2. Market Share Analysis, By Key Player
14.3. Competitive Scenario Analysis, By Key Player
14.3.1. New Product Launch & Enhancement
14.3.1.1. GenScript to Debut Expanded Synthetic Biology Product Line at SynBioBeta 2023
14.3.2. Investment & Funding
14.3.2.1. Series Funding to Support Expansion of DNA Synthesis Technology
14.3.2.2. NunaBio Raises EUR 1.9 million in Seed Funding to Expand Infrastructure and Accelerate R&D
15. Competitive Portfolio
15.1. Key Company Profiles
15.1.1. Ansa Biotechnologies, Inc.
15.1.2. Applied Biological Materials Inc.
15.1.3. Azenta Life Sciences
15.1.4. BGI Genomics Co., Ltd.
15.1.5. BioCat GmbH by AddLife AB
15.1.6. Biomatik Corporation
15.1.7. Bioneer Corporation
15.1.8. Biotage AB
15.1.9. Biotech Desk Pvt Ltd.
15.1.10. Boster Biological Technology
15.1.11. Camena Bioscience
15.1.12. Charles River Laboratories International, Inc.
15.1.13. Creative Biogene
15.1.14. Danaher Corporation
15.1.15. Elabscience Biotechnology Inc.
15.1.16. Eurofins Scientific SE
15.1.17. Evonetix Ltd.
15.1.18. GenCefe Biotech Limited
15.1.19. Gene Universal Inc.
15.1.20. General Biosystems, Inc.
15.1.21. GenScript Biotech Corporation
15.1.22. Macrogen, Inc.
15.1.23. NZYTech, Lda.
15.1.24. OriGene Technologies, Inc.
15.1.25. ProMab Biotechnologies, Inc.
15.1.26. ProteoGenix SA
15.1.27. Synbio Technologies
15.1.28. Telesis Bio Inc.
15.1.29. Thermo Fisher Scientific Inc.
15.1.30. Twist Bioscience Corporation
15.2. Key Product Portfolio
16. Appendix
16.1. Discussion Guide
16.2. License & Pricing
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
